Regulation of lipid metabolism by cytokines during host defense

Nutrition

Volumn 12, Issue 1 SUPPL. 1, 1996, Pages

  Grunfeld, Carl ^a   Feingold, Kenneth R ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

AIDS; Cachexia; Endotoxin; Interferon; Interleukin; TNF; Triglycerides

Indexed keywords

INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VERY LOW DENSITY LIPOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOREXIA; CACHEXIA; CONFERENCE PAPER; DISEASE CONTROL; ENZYME ACTIVATION; ENZYME ACTIVITY; HOST RESISTANCE; IMMUNE RESPONSE; LIPID METABOLISM; LIPOLYSIS; PRIORITY JOURNAL;

ADIPOCYTES; ANIMALS; CACHEXIA; CELLS, CULTURED; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNITY; LIPID METABOLISM;

EID: 0030010337     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/0899-9007(95)00073-9     Document Type: Article

References (26)

1. Hardardottir I, Grunfeld C, Feingold KR. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipid 1994;5:207
2. Feingold KR, Staprans I, Memon R, et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 1992;33:1765
3. Grunfeld C, Palladino MA. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 1990;35:45
4. Patton JS, Shepard HM, Wilking H, et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci USA 1986;83:8313
5. Doerrler W, Feingold KR, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994;6:478
6. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987;80:184
7. Feingold KR, Soued M, Serio MK, Moser AH, Dinarello CA, Grunfeld C. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 1989;125:267
8. Feingold KR, Adi S, Staprans I, et al. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Am J Physiol 1990;259:E177
9. Feingold KR, Soued M, Adi S, et al. Effect of interleukin-1 on lipid metabolism in the rat: similarities to and differences from tumor necrosis factor. Arterioscler Thromb 1991;11:495
10. Nonogaki K, Fuller GM, Fuentes NL, et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995;136:2143
11. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045
12. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696
13. Read TE, Grunfeld C, Kumwenda Z, et al. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med 1995;182:267
14. Feingold KR, Funk JL, Moser AH, Shigenaga JK, Rapp JH, Grunfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 1995;63:2041
15. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986;320:584
16. Marshall MK, Doerrler W, Feingold KR, Grunfeld C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 1994;135:141
17. Memon RA, Grunfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993;132:2246
18. Kurzrock R, Rohde MR, Quesada JR, et al. Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients. J Exp Med 1986;164:1093
19. Olsen EA, Lichtenstein GR, Wilkenson WE. Changes in serum lipids in patients with condylomata acuminata treated with interferon alpha-n1 (Welferon). J Am Acad Dermatol 1988;19:286
20. Hellerstein MK, Grunfeld C, Wu K, et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993;76:559
21. Grunfeld C, Kotler DP. Wasting in the acquired immunodeficiency syndrome. Semin Liver Dis 1992;12:175
22. Grunfeld C, Wilking H, Neese R, et al. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res 1989;49:2554
23. Grunfeld C, Kotler DP, Hamadeh R, et al. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27
24. Grunfeld C, Pang M, Shimizu L, et al. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55:455
25. Grunfeld C, Feingold KR. Tumor necrosis factor, cytokines and the hyperlipidemia of infection. Trends Endocrinol Metab 1991;2:213
26. Hajduk SL, Moore DR, Vasudevacharya J, et al. Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. J Biol Chem 1989;264:5210